Change in Hepatitis B Virus Large Surface Antigen Variant Prevalence 13 Years after Implementation of a Universal Vaccination Program in China

被引:56
|
作者
Bian, Tao [1 ,2 ]
Yan, Hongxia [1 ,3 ]
Shen, Liping [1 ]
Wang, Feng [1 ]
Zhang, Shuang [1 ]
Cao, Yanqiang [4 ]
Zhang, Shuo [1 ]
Zhang, Yong [1 ]
Bi, Shengli [1 ]
机构
[1] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China
[2] Univ N Carolina, Eshelman Sch Pharm, Div Mol Pharmaceut, Chapel Hill, NC USA
[3] Bur Hlth Inspect & Supervis Chaoyang Dist, Beijing, Peoples R China
[4] Hebei Entry Exit Inspect & Quarantine Bur, Shijiazhuang, Peoples R China
关键词
S-GENE; MOLECULAR EPIDEMIOLOGY; DETERMINANT VARIANTS; HBS ANTIBODIES; ESCAPE MUTANT; INFECTION; MUTATIONS; CHILDREN; CARRIERS; SECRETION;
D O I
10.1128/JVI.02127-13
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A nationwide hepatitis B virus (HBV) vaccination program was implemented in China starting in 1992. To study the change in HBV variant prevalence with massive immunization, large HBV surface protein (LHBs) genes from HBV surface antigen (HBsAg)-positive sera were amplified and sequenced. The prevalences of LHBs mutants were compared between the 1992 and 2005 surveys in child and adult groups. The prevalence of "alpha" determinant mutants in the children increased from 6.5% in 1992 to 14.8% in 2005, where the G145R mutant occurred most frequently. In contrast, mutation frequencies showed little difference between 1992 (9.4%) and 2005 (9.9%) in adults. Moreover, compared to the 1992 survey, the child group surface (S) protein mutation frequency specifically increased (P = 0.005) in the 2005 survey, but the pre-S region mutation frequency did not show a significant difference (P > 0.05). However, the mutation frequency in the adult group increased in both the pre-S and S regions. Furthermore, the frequencies of the disease-related pre-S2 deletion and start codon mutations were significantly higher in the adult groups than in the child groups in both the 1992 and 2005 surveys (P < 0.01). Massive immunization enhances the HBV S protein mutation; the prevalence of LHBs mutants, particularly disease-related mutants, tends to increase with patient age.
引用
收藏
页码:12196 / 12206
页数:11
相关论文
共 50 条
  • [1] Prevalence of hepatitis B surface antigen (HBsAg) in a blood donor population born prior to and after implementation of universal HBV vaccination in Shenzhen, China
    Wang, Zhen
    Zeng, Jinfeng
    Li, Tingting
    Zheng, Xin
    Xu, Xiaoxuan
    Ye, Xianlin
    Lu, Liang
    Zhu, Weigang
    Yang, Baocheng
    Allain, Jean-Pierre
    Li, Chengyao
    BMC INFECTIOUS DISEASES, 2016, 16
  • [2] Hepatitis B Virus Surface Antigen (HBsAg)-Positive and HBsAg-Negative Hepatitis B Virus Infection among Mother-Teenager Pairs 13 Years after Neonatal Hepatitis B Virus Vaccination
    Yao, Qing-Qing
    Dong, Xiao-Lian
    Wang, Xue-Cai
    Ge, Sheng-Xiang
    Hu, An-Qun
    Liu, Hai-Yan
    Wang, Yueping Alex
    Yuan, Quan
    Zheng, Ying-Jie
    CLINICAL AND VACCINE IMMUNOLOGY, 2013, 20 (02) : 269 - 275
  • [3] Survey of hepatitis B virus infection status after 35 years of universal vaccination implementation in Taiwan
    Chang, Kai-Chi
    Chang, Mei-Hwei
    Chen, Huey-Ling
    Cheng, Fang-Wen
    Wu, Jia-Feng
    Su, Wei-Ju
    Hsu, Hong-Yuan
    Ni, Yen-Hsuan
    LIVER INTERNATIONAL, 2024, 44 (08) : 2054 - 2062
  • [4] Prevalence of chronic hepatitis B virus infection before and after implementation of a hepatitis B vaccination program among children in Nepal
    Upreti, Shyam Raj
    Gurung, Santosh
    Patel, Minal
    Dixit, Sameer M.
    Krause, L. Kendall
    Shakya, Geeta
    Wannemuehler, Kathleen
    Rajbhandari, Rajesh
    Bohara, Rajendra
    Schluter, W. William
    VACCINE, 2014, 32 (34) : 4304 - 4309
  • [5] Hepatitis B immunity in adolescents and necessity for boost vaccination: 23 years after nationwide hepatitis B virus vaccination program in Taiwan
    Lu, John Jenn-Yenn
    Cheng, Chi-Chia
    Chou, Shieu-Ming
    Hor, Chang-Bor
    Yang, Yi-Chen
    Wang, Hsiang-Ling
    VACCINE, 2009, 27 (47) : 6613 - 6618
  • [6] Seroprevalence of hepatitis B virus in Taiwan 30 years after the commencement of the national vaccination program
    Hu, Yang-Cheng
    Yeh, Chih-Ching
    Chen, Ruey-Yu
    Su, Chien-Tien
    Wang, Wen-Chang
    Bai, Chyi-Huey
    Chan, Chi-Fen
    Su, Fu Hsiung
    PEERJ, 2018, 6
  • [7] Prevalence of hepatitis B virus infection and carriage after nineteen years of vaccination program in the Western Brazilian Amazon
    Miranda Braga, Wornei Silva
    Castilho, Marcia da Costa
    Borges, Fabiane Giovanella
    de Souza Martinho, Ana Cristina
    Rodrigues, Ivo Seixas
    de Azevedo, Eliete Pereira
    Scazufca, Marcia
    Menezes, Paulo Rossi
    REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2012, 45 (01) : 13 - 17
  • [8] Universal hepatitis B vaccination in Belgium: impact on serological markers 3 and 7 years after implementation
    Theeten, H.
    Hutse, V.
    Hoppenbrouwers, K.
    Beutels, P.
    Van Damme, P.
    EPIDEMIOLOGY AND INFECTION, 2014, 142 (02) : 251 - 261
  • [9] A molecular epidemiological study of the hepatitis B virus in Thailand after 22 years of universal immunization
    Yimnoi, Parichat
    Posuwan, Nawarat
    Wanlapakorn, Nasamon
    Tangkijvanich, Pisit
    Theamboonlers, Apiradee
    Vongpunsawad, Sompong
    Poovorawan, Yong
    JOURNAL OF MEDICAL VIROLOGY, 2016, 88 (04) : 664 - 673
  • [10] Analysis of HBsAg mutations in the 25 years after the implementation of the hepatitis B vaccination plan in China
    Ye, Huiming
    Teng, Jing
    Lin, Zhiyuan
    Wang, Ye
    Fu, Xiaochun
    VIRUS GENES, 2020, 56 (05) : 546 - 556